Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

Key facts

Where
San Antonio, United StatesSee the site

Where in United States

  • University of Texas Health Science CenterSan Antonio, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
The University of Texas Health Science Center at San Antonio
Trial code
NCT03160274
Record updated
5 November 2026
Original description
Pheochromocytomas and paragangliomas are neural crest-derived tumors of the nervous system that are often inherited and genetically heterogeneous. Genetic screening is recommended for patients and their relatives, and can guide clinical decisions. However, a mutation is not found in all cases. The aims of this proposal are to: 1) to map gene(s) involved in pheochromocytoma, and 2) identify genotype-phenotype correlations in patients with pheochromocytoma/paraganglioma of various genetic origins.Read full original descriptionShow less

Pheochromocytomas and paragangliomas are neural crest-derived tumors of the nervous system that are often inherited and genetically heterogeneous. Genetic screening is recommended for patients and their relatives, and can guide clinical decisions. However, a mutation is not found in all cases. The aims of this proposal are to: 1) to map gene(s) involved in pheochromocytoma, and 2) identify genotype-phenotype correlations in patients with pheochromocytoma/paraganglioma of various genetic origins.

Inclusion: diagnosis of pheochromocytoma and or paraganglioma; family member with diagnosis of pheochromocytoma and or paraganglioma; diagnosis of a pheochromocytoma- and or paraganglioma-associated condition; family member with diagnosis of a pheochromocytoma- and or paraganglioma-associated condition.

Exclusion: unconfirmed diagnosis of pheochromocytoma and/or paraganglioma or associated condition.

ClinicalTrials.gov NCT03160274